1. Home
  2. CTMX vs OSS Comparison

CTMX vs OSS Comparison

Compare CTMX & OSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • OSS
  • Stock Information
  • Founded
  • CTMX 2008
  • OSS 1998
  • Country
  • CTMX United States
  • OSS United States
  • Employees
  • CTMX N/A
  • OSS N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • OSS Computer Manufacturing
  • Sector
  • CTMX Health Care
  • OSS Technology
  • Exchange
  • CTMX Nasdaq
  • OSS Nasdaq
  • Market Cap
  • CTMX 85.3M
  • OSS 79.8M
  • IPO Year
  • CTMX 2015
  • OSS 2018
  • Fundamental
  • Price
  • CTMX $0.83
  • OSS $3.80
  • Analyst Decision
  • CTMX Buy
  • OSS Strong Buy
  • Analyst Count
  • CTMX 6
  • OSS 2
  • Target Price
  • CTMX $5.77
  • OSS $5.25
  • AVG Volume (30 Days)
  • CTMX 785.3K
  • OSS 294.8K
  • Earning Date
  • CTMX 03-10-2025
  • OSS 03-20-2025
  • Dividend Yield
  • CTMX N/A
  • OSS N/A
  • EPS Growth
  • CTMX N/A
  • OSS N/A
  • EPS
  • CTMX 0.16
  • OSS N/A
  • Revenue
  • CTMX $126,617,000.00
  • OSS $52,709,421.00
  • Revenue This Year
  • CTMX $22.55
  • OSS N/A
  • Revenue Next Year
  • CTMX N/A
  • OSS $9.40
  • P/E Ratio
  • CTMX $4.97
  • OSS N/A
  • Revenue Growth
  • CTMX 33.66
  • OSS N/A
  • 52 Week Low
  • CTMX $0.75
  • OSS $1.82
  • 52 Week High
  • CTMX $5.85
  • OSS $4.88
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 44.98
  • OSS 55.79
  • Support Level
  • CTMX $0.75
  • OSS $3.86
  • Resistance Level
  • CTMX $0.98
  • OSS $4.34
  • Average True Range (ATR)
  • CTMX 0.06
  • OSS 0.36
  • MACD
  • CTMX 0.00
  • OSS -0.01
  • Stochastic Oscillator
  • CTMX 36.00
  • OSS 48.77

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bresssner segment.

Share on Social Networks: